Literature DB >> 10833399

Cloning, expression, and one-step purification of the minimal essential domain of the light chain of botulinum neurotoxin type A.

S Kadkhodayan1, M S Knapp, J J Schmidt, S E Fabes, B Rupp, R Balhorn.   

Abstract

A truncated but functional form of the botulinum neurotoxin A light chain (Tyr 9-Leu 415) has been cloned into the three bacterial expression vectors, pET 28, pET 30, and PGEX-2T, and produced as fusion proteins. This 406-amino-acid light chain was expressed with 1 six-histidine tag (LC-pET28), 2 six histidine tags and a S-tag (LC-pET30), or a six-histidine tag and a glutathione S-transferase tag (LC-pGEX-2T). The three fusion proteins have been overexpressed in Escherichia coli, purified in a soluble form, and tested for protease activity. All three recombinant proteins were found to have similar enzymatic activity, comparable to the light chain purified from the whole toxin. The LC-pET30 protein was the most soluble and stable of the three fusion proteins, and it could be purified using a one-step affinity chromatography protocol. The purified protein was determined to be 98% pure as assessed by SDS-polyacrylamide gel. This protein has been crystallized and initial X-ray data show that the crystals diffract to 1.8 A. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833399     DOI: 10.1006/prep.2000.1227

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.

Authors:  Brent Segelke; Mark Knapp; Saloumeh Kadkhodayan; Rod Balhorn; Bernhard Rupp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

2.  Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.

Authors:  Joseph W Arndt; Wayne Yu; Fay Bi; Raymond C Stevens
Journal:  Biochemistry       Date:  2005-07-19       Impact factor: 3.162

3.  Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

Authors:  Jun-jun Shao; Jing-feng Wang; Hui-yun Chang; Ji-xing Liu
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

4.  Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.

Authors:  Jun-Jun Shao; Chung Kai Wong; Tong Lin; Shuk Kwan Lee; Guo-Zheng Cong; Fion Wai Yee Sin; Jun-Zheng Du; Shan-Dian Gao; Xiang-Tao Liu; Xue-Peng Cai; Yong Xie; Hui-Yun Chang; Ji-Xing Liu
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

5.  Novel Benzimidazole Inhibitors of Botulinum Neurotoxin/A Display Enzyme and Cell-Based Potency.

Authors:  Steven C Cardinale; Michelle M Butler; Gordon Ruthel; Jonathan E Nuss; Laura M Wanner; Bing Li; Ramdas Pai; Norton P Peet; Sina Bavari; Terry L Bowlin
Journal:  Botulinum J       Date:  2011

6.  In Vitro Expression and Production of Antibody Against Cymbidium mosaic virus Coat Protein.

Authors:  A R Sherpa; V Hallan; A A Zaidi
Journal:  Indian J Virol       Date:  2012-04-27

7.  Plasma membrane localization signals in the light chain of botulinum neurotoxin.

Authors:  Ester Fernández-Salas; Lance E Steward; Helen Ho; Patton E Garay; Sarah W Sun; Marcella A Gilmore; Joseph V Ordas; Joanne Wang; Joseph Francis; K Roger Aoki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

8.  A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin.

Authors:  Thomas M Feltrup; Kruti Patel; Raj Kumar; Shuowei Cai; Bal Ram Singh
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.